The role of STIM2 in melanoma is still poorly understood; however, a study by Stanisz et al. described that STIM2 might act both as a tumour suppressor in highly proliferative cells and a tumour promoter in specific invasive cancers in which increased basal [Ca2+]i results in a more invasive phenotype [138]. This evidence concerns the gene STIM2 and neoplasm.